Financing led by Ally Bridge Group, with participation from SOLVE FSHD, a venture philanthropy organization Lead program, EPI-321, is the first clinical application of epigenetic modulation in neuromuscular diseases, with…
To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System KIRKLAND, WA—Cardiac Dimensions®, a leader in minimally invasive treatments for…
Latest Funding Accelerates the Company’s Commercial Expansion SAN JOSE, CA—VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring, today announced the closing of $100 million in financing…
Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN…
Medical-device companies are raising big venture rounds to fortify their business and position themselves for a strong public offering or sale Venture investors are writing large checks to maturing medical-device…
Financing Fuels the Company’s Hypergrowth to Make Elevated Care Accessible to More Patients. Petrovic’s Appointment Positions Imperative Care for Long Term Success and Scale. CAMPBELL, CA—(BUSINESS WIRE)—Imperative Care, Inc., a…
Kestra Medical Technologies, Inc. announced today an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with its…
Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead Robust Investor Syndicate. FOR IMMEDIATE RELEASE: HAIFA, ISRAEL AND MIAMI, FL—Insightec, a global healthcare company…
– Proceeds will support clinical development of lead pipeline candidates: ENV-101 for fibrotic lung diseases including idiopathic pulmonary fibrosis, and ENV-501, a next-generation HER3-targeted antibody-drug conjugate, for solid tumors –…
NEW YORK—(BUSINESS WIRE)—Ally Bridge Group (“ABG”), a leading global healthcare investment firm focused on high-impact life science innovation, today announced several key promotions within its investment team and a new…
